These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 30922100

  • 1. Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.
    Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH.
    Am J Psychiatry; 2019 May 01; 176(5):358-366. PubMed ID: 30922100
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P, Yang J, Dass N, Vale V, Keller AS, Irvin J, Taylor Z, Basu S, Ng A, Williams LM.
    JAMA Netw Open; 2020 Jun 01; 3(6):e206653. PubMed ID: 32568399
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
    De La Garza N, Rush AJ, Killian MO, Grannemann BD, Carmody TJ, Trivedi MH.
    Depress Anxiety; 2019 Apr 01; 36(4):313-320. PubMed ID: 30370613
    [Abstract] [Full Text] [Related]

  • 9. Association between irritability and suicidal ideation in three clinical trials of adults with major depressive disorder.
    Jha MK, Minhajuddin A, Chin Fatt C, Kircanski K, Stringaris A, Leibenluft E, Trivedi MH.
    Neuropsychopharmacology; 2020 Dec 01; 45(13):2147-2154. PubMed ID: 32663842
    [Abstract] [Full Text] [Related]

  • 10. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
    Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.
    Am J Psychiatry; 2006 Jul 01; 163(7):1161-72. PubMed ID: 16816220
    [Abstract] [Full Text] [Related]

  • 11. Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study.
    Minhajuddin A, Jha MK, Fatt CC, Trivedi MH.
    Psychiatr Res Clin Pract; 2020 Jul 01; 2(1):10-18. PubMed ID: 36101888
    [Abstract] [Full Text] [Related]

  • 12. Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
    Jha MK, Malchow AL, Grannemann BD, Rush AJ, Trivedi MH.
    Neuropsychopharmacology; 2018 Oct 01; 43(11):2197-2203. PubMed ID: 30135556
    [Abstract] [Full Text] [Related]

  • 13. Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale.
    Jha MK, Minhajuddin A, South C, Rush AJ, Trivedi MH.
    Int J Neuropsychopharmacol; 2018 Apr 01; 21(4):325-332. PubMed ID: 29182724
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Bobo WV, Chen H, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Lesser IM, Kornstein SG, Wisniewski SR, Rush AJ, Shelton RC.
    J Affect Disord; 2011 Oct 01; 133(3):467-76. PubMed ID: 21601287
    [Abstract] [Full Text] [Related]

  • 15. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 01; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 16. Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
    Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A.
    J Affect Disord; 2019 May 01; 250():419-424. PubMed ID: 30878654
    [Abstract] [Full Text] [Related]

  • 17. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.
    Rush AJ, Trivedi MH, Stewart JW, Nierenberg AA, Fava M, Kurian BT, Warden D, Morris DW, Luther JF, Husain MM, Cook IA, Shelton RC, Lesser IM, Kornstein SG, Wisniewski SR.
    Am J Psychiatry; 2011 Jul 01; 168(7):689-701. PubMed ID: 21536692
    [Abstract] [Full Text] [Related]

  • 18. Trial of Psilocybin versus Escitalopram for Depression.
    Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ.
    N Engl J Med; 2021 Apr 15; 384(15):1402-1411. PubMed ID: 33852780
    [Abstract] [Full Text] [Related]

  • 19. What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.
    Rush AJ, South C, Jha MK, Jain SB, Trivedi MH.
    J Clin Psychiatry; 2020 Aug 11; 81(5):. PubMed ID: 32780949
    [Abstract] [Full Text] [Related]

  • 20. Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
    Jha MK, Wakhlu S, Dronamraju N, Minhajuddin A, Greer TL, Trivedi MH.
    J Affect Disord; 2018 Jul 11; 234():34-37. PubMed ID: 29522941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.